Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Virtual-reality self-hypnosis for HIV-related chronic pain

Official title: An Open-label Study of Self-hypnosis Software for Virtual Reality for the Treatment of HIV-associated Chronic Pain - a Development and Usability Study

Run by Icahn School of Medicine at Mount Sinai · NCT06398847 · Data updated 2026-11-12

This trial will try a virtual-reality self-hypnosis program to see if it reduces chronic pain in adults living with HIV.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMarch 26, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJuly 27, 2026
Trial IDNCT06398847 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) living with HIV who have had chronic HIV-associated pain for at least 90 days, are on a stable antiretroviral regimen and stable pain management for ≥90 days, report average pain ≥3, speak English, and can access the internet are ideal candidates.

Probably not a fit

Patients with unstable medical or psychiatric conditions, those currently in other investigational pain protocols, or those unable to tolerate or use VR technology are less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project uses an off-the-shelf VR headset (OculusGo) paired with self-hypnosis software developed by the study team to test safety, usability, and preliminary pain relief. Work is organized in two phases: Phase A involves software development and internal testing by the team, and Phase B enrolls participants to use the VR intervention. This single-site study at the Icahn School of Medicine at Mount Sinai received an FDA non-significant risk exemption. Participants will be adults with documented HIV-associated chronic pain on stable antiretroviral and pain regimens and will report baseline pain intensity of at least 3 on the numeric rating scale.

Why it matters

Potential benefit: If successful, this could provide a non-drug, accessible tool to lessen HIV-associated chronic pain symptoms.

How similar studies have gone: Prior work shows VR and self-hypnosis can reduce pain in other chronic pain groups, but combining VR-delivered self-hypnosis specifically for HIV-related pain is relatively novel and has only preliminary data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patient Eligibility

Inclusion Criteria:

* Adults age ≥18
* Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days.
* Documentation of chronic pain associated with HIV for≥90 days
* Stable pain management regimen ≥90 days, or no pain treatments ≥90 days
* Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2
* Access to the internet via smartphone, computer, or tablet 7. Fluent in English
* Capable of giving informed consent and willingness to comply with study procedures.

Exclusion Criteria:

* A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention.
* Concurrent participation in another investigational protocol for pain treatment
* A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures.
* Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices.
* A medical condition predisposing prospective participant to nausea or dizziness 6. Lack of stereoscopic vision or severe hearing impairment
* Injury to eyes, face, or neck that impedes using the VR device
* If participant has access to personal VR gear for gaming or other purposes at home, participant fails to agree not to use these personal VR gear during the course of the protocol.
* Currently pregnant or planning to become pregnant during the study period

Where it's running

  • Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.